Moreover, tyrosine phosphorylation of KCC2 is likely to play a key role in regulating the degradation of KCC2, a process that may be responsible for the pathologic loss of KCC2 function that is evident in SE and other forms of epilepsy [50,51]. The gene discussed is SLC12A5; the disease is epilepsy.